← Leaderboards
Emma J Chory
Stanford University
$293,467
Attributed
$293,467
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $69.8K · FY2016–22$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$293,467 · 2
By mechanism
F32$201,118 · 1
F31$92,349 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Laura D Attardi$23,311,175
- Adrian Tristan Keatinge-Clay$5,265,401
- Shiou-Chuan Tsai$3,558,327
- Joseph Steven Lipsick$10,255,196
- Edward I Solomon$24,141,500
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeInterestMalignant NeoplasmsResistanceCellsGenomeProteinsMolecularTranscription FactorInhibitor/AntagonistFaceBiological AvailabilityBiomimeticsBacteriaEnzymesEvolutionFda ApprovedDesignCodon NucleotidesActive SitesCost EffectiveDehydrationAmino AcidsCost
Grant awards (6)
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics$69,802
F32 · FY2022 · CA · contact PI
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics$66,390
F32 · FY2021 · CA · contact PI
Genomic incorporation of stapled peptides for cost effective discovery and synthesis of novel therapeutics$64,926
F32 · FY2020 · CA · contact PI
HIJACKING OF SUPER-ENHANCERS FOR CANCER-SPECIFIC THERAPEUTICS$21,591
F31 · FY2018 · CA · contact PI
HIJACKING OF SUPER-ENHANCERS FOR CANCER-SPECIFIC THERAPEUTICS$35,613
F31 · FY2017 · CA · contact PI
HIJACKING OF SUPER-ENHANCERS FOR CANCER-SPECIFIC THERAPEUTICS$35,145
F31 · FY2016 · CA · contact PI